Evidence map›Paper›PMID 33712032›Full record

ArticleHarm reduction journal2021

"My first 48 hours out": drug users' perspectives on challenges and strategies upon release from prison.

Daniela Jamin, Wouter Vanderplasschen, Orphée Sys, Marie Jauffret-Roustide, Laurent Michel, Philippe Trouiller, Andreia Neisa, Mariana Homen, Vânia Mendes, Heino Stöver

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. [Take-home naloxone: a building block of drug emergency prophylaxis in Germany].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Daniela JaminInstitute for Addiction Research, Frankfurt University of Applied Sciences, Frankfurt, Germany. jamin@fb4.fra-uas.de.ORCID 0000-0002-9339-7208
Wouter VanderplasschenDepartment of Special Needs Education, Ghent University, Ghent, Belgium.
Orphée SysDepartment of Special Needs Education, Ghent University, Ghent, Belgium.
Marie Jauffret-RoustideCermes 3 (Inserm U988/CNRS UMR 8211/EHESS/), Université de Paris, Paris, France.
Laurent MichelCESP, INSERM UMR1018, University Paris - Saclay, Pierre Nicole Centre, French Red Cross, Paris, France.
Philippe TrouillerCESP, INSERM UMR1018, University Paris - Saclay, Pierre Nicole Centre, French Red Cross, Paris, France.
Andreia NeisaAPDES, Agência Piaget Para O Desenvolvimento, Villa Nova de Gaia, Portugal.
Mariana HomenAPDES, Agência Piaget Para O Desenvolvimento, Villa Nova de Gaia, Portugal.
Vânia MendesAPDES, Agência Piaget Para O Desenvolvimento, Villa Nova de Gaia, Portugal.
Heino StöverInstitute for Addiction Research, Frankfurt University of Applied Sciences, Frankfurt, Germany.
Instituto Piaget · PTGhent University · BEGoethe University Frankfurt · DEInserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrisoners report much higher prevalence rates of drug use and more harmful consumption patterns than the general population. People who use drugs have above-average experiences with the criminal justice system in general, and the prison system and subsequent release situations in particular. Release from prison is associated with increased mortality rates among drug users due to the risk of overdose. The EU-funded project 'My first 48 hours out' aimed to address the gaps in continuity of care for long-term drug users in prison and upon release, with a special focus on drug user's perspectives on needs and challenges upon release.

methodsA multi-country (Belgium, France, Germany and Portugal) qualitative study was set up to explore drug users' perceptions of drug use and risk behaviour upon prison release, experiences of incarceration and release, and strategies to avoid risks when being released. In total, 104 prisoners and recently released persons with a history of drug use participated in semi-structured interviews and focus groups discussions on these topics.

resultsRespondents pointed out that there are numerous challenges for people who use drugs when released from prison. Lack of stable housing and employment support were frequently mentioned, as well as complex administrative procedures regarding access to services, health insurance and welfare benefits. Besides structural challenges, individual issues may challenge social reintegration like 'old habits', mental health problems and disrupted social networks. As a result, (ex-)prisoners adopt individual strategies to cope with the risks and challenges at release.

conclusionMeasures to prepare prisoners for release often do not focus on the individual and specific challenges of persons who use drugs. Psychosocial and medical support need to be improved and adjusted to drug users' needs inside and outside prison. To improve the quality and continuity of care around release, the perspectives and coping strategies of people who use drugs should be used to better address their needs and barriers to treatment.

Indexed as

Drug OverdoseDrug UsersPrisonersSubstance-Related DisordersHumansPrisonsDrug useHarm reductionOverdosePrisonRecoveryReleaseRisk behaviour

Identifiers

PMID33712032
PMCPMC7953692
OpenAlexW3134422996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.